A Study Comparing User Experience of Different Delivery Devices for Glucagon

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of the study is to learn more about different devices for delivering glucagon during simulations of severe hypoglycemic (low blood sugar) emergencies. The study will be carried out using medical manikins to simulate real life scenarios. No drug will be administered to humans. Part A will last approximately 17 days for Trained Users and Participants with Diabetes (PWD). Part B will last approximately nine (9) days for Untrained Users. Each part will be separated by approximately 7 days.

Key facts

Study ID
NCT03765502
Run by
Eli Lilly and Company
People needed
99
Starts
2018-11-19
Expected to finish
2019-01-03
Last updated by the study team
2020-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.